Potentials of ribosomopathy gene as pharmaceutical targets for cancer treatment
Ribosomopathies encompass a spectrum of disorders arising from impaired ribosome biogenesis and reduced functionality. Mutation or dysexpression of the genes that disturb any finely regulated steps of ribosome biogenesis can result in different types of ribosomopathies in clinic, collectively known...
Збережено в:
| Автори: | , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Elsevier
2024-03-01
|
| Серія: | Journal of Pharmaceutical Analysis |
| Предмети: | |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S2095177923002599 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|